- https://www.novartis.com/news/global-health-corporate-responsibility
Novartis transforms its Global Health & Corporate Responsibility organization.
- https://www.novartis.com/news/achieving-100-renewable-electricity
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
- https://www.novartis.com/news/novartis-appoints-marc-boutin-global-head-patient-engagement-advocacy
Novartis has appointed Marc Boutin as Global Head of Patient Engagement & Advocacy. He will join Novartis no later than November 1, 2020.
- https://www.novartis.com/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd
- https://www.novartis.com/news/novartis-2021-financial-results
Novartis announces the company’s fourth quarter and 2021 full year financial results.
- https://www.novartis.com/news/avexis-data-integrity-updates
Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement
- https://www.novartis.com/news/novartis-co-creating-impact-summit-2021
Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.
- https://www.novartis.com/news/novartis-announces-european-patent-office-orders-grant-european-gilenya-fingolimod-05mg-daily-dose-patent
- https://www.novartis.com/news/uncovering-profound-and-under-reported-effects-people-living-sickle-cell-disease
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.
- https://www.novartis.com/news/epis-explores-how-covid-19-shaping-future-digital-engagement-within-healthcare
Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 19
- › Next page